Jérôme Busserolles Selected Research

Jérôme Busserolles Research Topics

Disease

13	Pain (Aches) 12/2023 - 01/2011
11	Peripheral Nervous System Diseases (PNS Diseases) 12/2023 - 03/2012
8	Neuralgia (Stump Neuralgia) 12/2023 - 02/2016
6	Hypersensitivity (Allergy) 05/2022 - 01/2011
4	Neoplasms (Cancer) 05/2022 - 03/2012
4	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 01/2018
3	Hyperalgesia 12/2023 - 03/2012
3	Chronic Pain 01/2016 - 01/2013
3	Inflammation (Inflammations) 08/2015 - 05/2005
2	Multiple Myeloma 04/2022 - 01/2021
2	Respiratory Insufficiency (Respiratory Failure) 10/2020 - 01/2013
2	Constipation 10/2020 - 01/2013
2	Cold Hypersensitivity 01/2018 - 05/2011
1	Alzheimer Disease (Alzheimer's Disease) 05/2022
1	Channelopathies 12/2021
1	Nociceptive Pain 01/2020
1	Opioid-Related Disorders (Opiate Addiction) 01/2020
1	Cancer Pain 01/2020
1	Polyps 01/2018
1	Wounds and Injuries (Trauma) 03/2012
1	Colonic Neoplasms (Colon Cancer) 01/2006
1	Body Weight (Weight, Body) 01/2006
1	Carcinogenesis 01/2006
1	Colitis 05/2005
1	Hyperlipidemias (Hyperlipidemia) 06/2003
1	Magnesium Deficiency (Deficiency, Magnesium) 03/2003
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2002

Drug/Important Bio-Agent (IBA)

10	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2023 - 05/2011
6	Analgesics (Analgesic Drugs)IBA 05/2022 - 01/2016
5	Bortezomib (Velcade)FDA Link 12/2023 - 08/2015
5	Ion Channels (Ion Channel)IBA 12/2021 - 05/2011
4	potassium channel protein TREK-1IBA 01/2018 - 01/2013
3	Paclitaxel (Taxol)FDA LinkGeneric 12/2023 - 03/2012
3	Potassium Channels (Potassium Channel)IBA 12/2021 - 02/2016
3	Opioid Analgesics (Opioids)IBA 01/2021 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 12/2023 - 10/2019
2	Vincristine (Oncovin)FDA LinkGeneric 12/2023 - 05/2022
2	Messenger RNA (mRNA)IBA 07/2021 - 01/2011
2	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2021 - 06/2020
2	CannabinoidsIBA 01/2021 - 08/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2012 - 10/2002
2	AntioxidantsIBA 01/2006 - 10/2002
2	FructoseIBA 06/2003 - 10/2002
2	Sucrose (Saccharose)IBA 03/2003 - 10/2002
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023
1	Indicators and Reagents (Reagents)IBA 12/2023
1	Acetylcholine (Acetylcholine Chloride)FDA Link 05/2022
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 05/2022
1	Cholinergic Agents (Cholinergics)IBA 05/2022
1	Donepezil (Aricept)FDA LinkGeneric 05/2022
1	Histone Deacetylase InhibitorsIBA 12/2021
1	entinostat (MS 275)IBA 12/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2021
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 06/2020
1	Antidepressive Agents (Antidepressants)IBA 06/2020
1	Riluzole FDA LinkGeneric 01/2018
1	Taxoids (Taxanes)IBA 08/2015
1	PlatinumIBA 08/2015
1	SaltsIBA 08/2015
1	Thalidomide (Thalomid)FDA Link 08/2015
1	Vinca AlkaloidsIBA 08/2015
1	eribulin FDA Link 08/2015
1	Neuroprotective AgentsIBA 08/2015
1	Epothilones (Epothilone)IBA 08/2015
1	Antineoplastic Agents (Antineoplastics)IBA 05/2015
1	Sodium Channels (Sodium Channel)IBA 05/2015
1	Dinoprostone (PGE2)FDA Link 12/2014
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 11/2013
1	Glutamic Acid (Glutamate)FDA Link 11/2013
1	Morphine (MS Contin)FDA LinkGeneric 01/2013
1	Streptozocin (Streptozotocin)FDA Link 03/2012
1	CationsIBA 03/2012
1	Antimitotic AgentsIBA 03/2012
1	NAD (NADH)IBA 03/2012
1	CarrageenanIBA 01/2011
1	Freund's AdjuvantIBA 01/2011
1	BilirubinIBA 01/2006
1	Biliverdine (Biliverdin)IBA 01/2006
1	Heme Oxygenase-1IBA 01/2006
1	procyanidinIBA 01/2006
1	bolinaquinoneIBA 05/2005
1	petrosaspongiolide mIBA 05/2005
1	AcidsIBA 05/2005
1	Triglycerides (Triacylglycerol)IBA 06/2003
1	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 03/2003
1	Estrogens (Estrogen)FDA Link 10/2002

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 12/2023 - 01/2006
3	Therapeutics 01/2016 - 03/2012
1	Analgesia 01/2013